EphA3/A4/A5 Antibody [A18J10]

Catalog No.: F8255

    Application: Reactivity:
    • Lane 1: MOLT-4, Lane 2: NIH/3T3
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:1000
    1:100
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    135 kDa
    ポジティブコントロール SNB19 cells; MOLT-4 cells; mIMCD-3 cells; NIH/3T3 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    EphA3/A4/A5 Antibody [A18J10] detects endogenous levels of total EphA3, EphA4, and EphA5 proteins.
    タンパク質の局在
    細胞膜、細胞突起、細胞外環境、細胞接着、エンドソーム、シナプス後部、シナプス
    Uniprot ID
    P54756; P29320; P54764
    Clone
    A18J10
    Synonym(s)
    Ephrin type-A receptor 3/4/5; EPHA3; EPHA4; EPHA5
    Background
    EphA3/A4/A5 receptors belong to the Eph family of receptor tyrosine kinases, specifically the EphA subclass that preferentially engages GPI-anchored ephrin-A ligands to orchestrate cell-cell repulsion and topographic mapping during development. These receptors share an extracellular ligand-binding domain, cysteine-rich region, and intracellular kinase domain with SAM and PDZ-binding motifs that recruit adaptors like Nck and Crk for signal propagation. Ligand binding induces receptor clustering and autophosphorylation, activating PI3K-AKT and MAPK/ERK cascades alongside Rho GTPase modulation through ephexin and Vav exchange factors that drive actin cytoskeleton contraction and lamellipodial retraction essential for contact repulsion. EphA3 preferentially pairs with ephrin-A5 through a tilted high-affinity interface where the ephrin G-H loop inserts into the receptor pocket, stabilizing a conformation that enhances kinase activation compared to EphA2 while EphA4 and A5 exhibit overlapping specificities that fine-tune retinotectal projections and callosal axon guidance via graded signaling gradients. Forward signaling suppresses AKT to promote apoptosis and cell cycle arrest in tumor contexts, while somatic mutations in kinase or ligand-binding domains disrupt this tumor-suppressive function, permitting unchecked proliferation and metastasis in lung, colorectal, and breast cancers. EphA3 governs cardiac mesenchyme migration, and EphA4 coordinates hindbrain segmentation alongside vascular patterning through repulsive cues that prevent aberrant tissue fusion. Dysregulation through inactivating mutations correlates with lung cancer progression and angiogenesis in gastric carcinoma, while EphA5 maintains topographic retinal projections.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください